BR9709529A - Leptin fragments (ob protein) - Google Patents

Leptin fragments (ob protein)

Info

Publication number
BR9709529A
BR9709529A BR9709529A BR9709529A BR9709529A BR 9709529 A BR9709529 A BR 9709529A BR 9709529 A BR9709529 A BR 9709529A BR 9709529 A BR9709529 A BR 9709529A BR 9709529 A BR9709529 A BR 9709529A
Authority
BR
Brazil
Prior art keywords
protein
leptin fragments
leptin
fragments
Prior art date
Application number
BR9709529A
Other languages
Portuguese (pt)
Inventor
Kamal A Al-Barazanji
Jonathan Robert Sanders Arch
Patrick Camilleri
William Arthur Neville
Original Assignee
Smithkline Beecham P L C Socie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9611775.9A external-priority patent/GB9611775D0/en
Priority claimed from GBGB9618540.0A external-priority patent/GB9618540D0/en
Priority claimed from GBGB9703493.8A external-priority patent/GB9703493D0/en
Application filed by Smithkline Beecham P L C Socie filed Critical Smithkline Beecham P L C Socie
Publication of BR9709529A publication Critical patent/BR9709529A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9709529A 1996-06-06 1997-06-04 Leptin fragments (ob protein) BR9709529A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9611775.9A GB9611775D0 (en) 1996-06-06 1996-06-06 Novel compounds
GBGB9618540.0A GB9618540D0 (en) 1996-09-05 1996-09-05 Novel compounds
GBGB9703493.8A GB9703493D0 (en) 1997-02-20 1997-02-20 Novel compounds
PCT/EP1997/002968 WO1997046585A2 (en) 1996-06-06 1997-06-04 Fragments of leptin (ob protein)

Publications (1)

Publication Number Publication Date
BR9709529A true BR9709529A (en) 1999-08-10

Family

ID=27268305

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709529A BR9709529A (en) 1996-06-06 1997-06-04 Leptin fragments (ob protein)

Country Status (15)

Country Link
EP (1) EP0912609A2 (en)
JP (1) JP2000512137A (en)
KR (1) KR20000016402A (en)
CN (1) CN1221426A (en)
AR (1) AR008765A1 (en)
AU (1) AU3337297A (en)
BR (1) BR9709529A (en)
CA (1) CA2257240A1 (en)
CZ (1) CZ397898A3 (en)
IL (1) IL127153A0 (en)
NO (1) NO985683D0 (en)
NZ (1) NZ332879A (en)
PL (1) PL330361A1 (en)
TR (1) TR199802534T2 (en)
WO (1) WO1997046585A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2335107C (en) 1998-07-28 2010-01-19 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Leptin-mediated gene-induction
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
CA2388417A1 (en) * 1999-09-22 2001-03-29 Genset Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases
EP1283878B1 (en) 2000-05-22 2005-07-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Receptor-based interaction trap
CA2464277C (en) 2001-10-22 2013-02-05 Amgen, Inc. Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
WO2005023288A1 (en) 2003-09-08 2005-03-17 Applied Research Systems Ars Holding N.V. Treatment of fibrotic disease
EP2417980A1 (en) 2004-02-11 2012-02-15 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties
EP1812038A1 (en) 2004-11-18 2007-08-01 VIB vzw Fibronectin iii domain as leptin receptor antagonists
US20090286723A1 (en) 2005-02-11 2009-11-19 Amylin Pharmaceuticals, Inc. Hybrid Polypeptides with Selectable Properties
US8404637B2 (en) 2005-02-11 2013-03-26 Amylin Pharmaceuticals, Llc GIP analog and hybrid polypeptides with selectable properties
US7629315B2 (en) 2005-03-09 2009-12-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compositions for blocking the inhibitory effect of human CRP on human leptin
EP2330125A3 (en) 2005-08-11 2012-12-12 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
ES2319048B1 (en) * 2007-06-20 2010-02-10 Universitat De Les Illes Balears USE OF LEPTINE IN THE TREATMENT OF ALTERATIONS IN FOOD HABITS.
US8889622B2 (en) 2007-07-25 2014-11-18 Washington University Methods of inhibiting seizure in a subject
GB2451858A (en) * 2007-08-15 2009-02-18 Sergiy Konovchuk Methods of reducing body fat and treating obesity
BRPI0820950A2 (en) 2007-12-05 2015-07-07 Astrazeneca Ab Compound, pharmaceutical formulation, use of a compound, methods for treating or preventing conditions or diseases and for inhibiting angiogenesis, and process for preparing a compound.
CN102026975A (en) 2007-12-05 2011-04-20 阿斯利康(瑞典)有限公司 Piperazines as anti-obesity agents
CN102245183A (en) * 2008-06-04 2011-11-16 阿斯利康(瑞典)有限公司 New compounds v
WO2009147216A1 (en) * 2008-06-04 2009-12-10 Biovitrum Ab (Publ) New pyridine derivatives as leptin receptor modulator mimetics
WO2010118384A2 (en) 2009-04-10 2010-10-14 Amylin Pharmaceuticals, Inc. Amylin agonist compounds for estrogen-deficient mammals
WO2011143280A2 (en) * 2010-05-11 2011-11-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling
DK2621519T3 (en) 2010-09-28 2017-10-16 Aegerion Pharmaceuticals Inc Leptin-ABD fusion polypeptides with improved duration of action
CN104829707B (en) * 2015-05-06 2017-12-19 广东省生物资源应用研究所 The leptin activity peptide and its encoding gene and application of one CD ring and E spiral region mutations
CN110183530A (en) * 2019-06-21 2019-08-30 深圳市亚辉龙生物科技股份有限公司 Leptin immunogene, hybridoma, monoclonal antibody, polyclonal antibody and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
WO1996023815A1 (en) * 1995-01-31 1996-08-08 Eli Lilly And Company Ob gene product antibodies
US5552523A (en) * 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
WO1996023514A1 (en) * 1995-01-31 1996-08-08 Eli Lilly And Company Anti-obesity proteins
AU5539596A (en) * 1995-04-06 1996-10-23 Amylin Pharmaceuticals, Inc. Anti-obesity agents
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
WO1997046585A3 (en) 1998-04-23
AR008765A1 (en) 2000-02-23
EP0912609A2 (en) 1999-05-06
PL330361A1 (en) 1999-05-10
NZ332879A (en) 2000-09-29
CN1221426A (en) 1999-06-30
JP2000512137A (en) 2000-09-19
TR199802534T2 (en) 1999-03-22
NO985683L (en) 1998-12-04
CZ397898A3 (en) 1999-04-14
IL127153A0 (en) 1999-09-22
NO985683D0 (en) 1998-12-04
KR20000016402A (en) 2000-03-25
AU3337297A (en) 1998-01-05
CA2257240A1 (en) 1997-12-11
WO1997046585A2 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
BR9709529A (en) Leptin fragments (ob protein)
DE69724557D1 (en) document analysis
DE69722620D1 (en) NON-AQUEOUS PROTICAL PEPTIDE PREPARATIONS
NO985680L (en) peptide
NO983849L (en) peptide
DE59707298D1 (en) DESODORING PREPARATIONS
DK0832553T3 (en) combine
GB9614033D0 (en) Modified protein G and fragments thereof
TR199701666A3 (en) Proteins
DE69925271D1 (en) ANGIOSTATIN-BINDING PROTEIN
DE69718328D1 (en) magnetron
FR2865535B1 (en) indenter
DE59602924D1 (en) Bone rasp
DE59702387D1 (en) MEDICAL PLIERS
KR970004260U (en) Orthopedic Colset
BR7601137U (en) Bone
GB9604865D0 (en) Modified proteins
KR970059003U (en) Joint Boot
KR970064121U (en) magnetron
SE9602287D0 (en) Novel protein and methods for its use
SE9601761D0 (en) T-valve procedure
ID16704A (en) HEALING METHOD
UA1371S (en) NAIL
KR970052198U (en) nail
UA1372S (en) NAIL

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.PORTANTO, INDEFIRO O PRESENTE PEDIDO.